CIPO trademark

SIERRA ONCOLOGY

RegisteredCIPOWord markClass 5

"SIERRA ONCOLOGY" is a word mark owned by GlaxoSmithKline LLC, filed at the CIPO on February 27, 2017. It is registered and covers class 5 (Pharmaceuticals).

View GlaxoSmithKline LLC portfolioGet this data via the API
Official CIPO record
SIERRA ONCOLOGY
Word mark as filed with the CIPO
Status
Registered
Since October 17, 2019
Filed
February 27, 2017
Registered
October 17, 2019
Expires
October 17, 2029
Application no.
1824703
Registration no.
TMA1059415
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns SIERRA ONCOLOGY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GlaxoSmithKline LLC

United States

857 trademarks in the portfolioView company

Representative

Norton Rose Fulbright Canada LLP/S.e.n.c.r.l.,s.r.l.

Norton Rose Fulbright Canada LLP/S.e.n.c.r.l.,s.r.l.

Goods and services

What the mark covers

The products and services SIERRA ONCOLOGY is filed for, grouped by Nice class.

  • Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of cancer, namely blood cancers and solid tumors; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of cancer related diseases, namely anemia, thrombocytopenia, neutropenia, fatigue; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of disorders and infections of the endocrine system, namely growth and thyroid disorders; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue or organ implantation.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Change of Title Registered; Assignment/Cession
  2. FROM/DE: Sierra Oncology LLC; TO/A: GlaxoSmithKline LLC
  3. Amendment to Registration; Name and Address/Nom et address
  4. Owner Address Change / Changement d'adresse du propriétaire
  5. Amendment to Registration; Address/address
  6. Assignment Correspondence Created
  7. FROM/DE: SIERRA ONCOLOGY INC.; TO/A: Sierra Oncology LLC
  8. Registered
  9. Registration Fee Notice Sent
  10. Registration Pending

9 earlier steps on the official record.

FAQ

About SIERRA ONCOLOGY

Who owns the trademark "SIERRA ONCOLOGY"?

The CIPO trademark "SIERRA ONCOLOGY" (application 1824703) is owned by GlaxoSmithKline LLC.

What is the status of "SIERRA ONCOLOGY"?

Its status at the CIPO is: registered.

When was "SIERRA ONCOLOGY" registered?

It was registered on October 17, 2019 and is due to expire on October 17, 2029.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SIERRA ONCOLOGY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb63-68bf-76cc-918a-8ca9b11b3acb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb63-68bf-76cc-918a-8ca9b11b3acb",
  "object": "trademark",
  "mark_text": "SIERRA ONCOLOGY",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "1824703",
  "filing_date": "2017-02-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "GlaxoSmithKline LLC",
      "entity_id": "ent_019ebbad-4be6-7544-bafb-06b4c2a2ecb2"
    }
  ]
}